Combination therapy with intensive granulocyte and monocyte adsorptive apheresis plus adalimumab: Therapeutic outcomes in 5 cases with refractory Crohn's disease

Case Reports in Gastroenterology

Volumn 6, Issue 3, 2012, Pages 765-771

  Ozeki, Keiji ^a   Tanida, Satoshi ^a   Mizoshita, Tsutomu ^a   Tsukamoto, Hironobu ^a   Ebi, Masahide ^a   Mori, Yoshinori ^a   Kataoka, Hiromi ^a   Kamiya, Takeshi ^a   Joh, Takashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Adalimumab; Clinical remission; Intensive adsorptive granulocyte and monocyte apheresis; Refractory Crohn's disease; Simple endoscopic score for Crohn's disease

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; INFLIXIMAB; METRONIDAZOLE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; APHERESIS; ARTICLE; BRONCHITIS; CLINICAL ARTICLE; COLON CROHN DISEASE; COLON FISTULA; COLON ULCER; COLONOSCOPY; CROHN DISEASE ACTIVITY INDEX; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; INTENSIVE ADSORPTIVE GRANULOCYTE AND MONOCYTE APHERESIS; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; THERAPY; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84873135851     PISSN: None     EISSN: 16620631     Source Type: Journal    
DOI: 10.1159/000346312     Document Type: Article

References (15)

1. Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack P: Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: The CLASSIC-I trial. Gastroenterology 2006;130:323-333; quiz 591
2. Sandborn WJ, Hanauer SB, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh DG, Panaccione R, Wolf D, Kent JD, Bittle B, Li J, Pollack PF: Adalimumab for maintenance treatment of Crohn's disease: Results of the CLASSIC II trial. Gut 2007;56:1232-1239
3. Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, Schreiber S, Byczkowski D, Li J, Kent JD, Pollack PF: Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial. Gastroenterology 2007;132:52-65
4. Saniabadi AR, Hanai H, Fukunaga K, Sawada K, Shima C, Bjarnason I, Lofberg R: Therapeutic leukocytapheresis for inflammatory bowel disease. Transfus Apher Sci 2007;37:191-200
5. Fukuda Y, Matsui T, Suzuki Y, Kanke K, Matsumoto T, Takazoe M, Motoya S, Honma T, Sawada K, Yao T, Shimoyama T, Hibi T: Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: An open multicenter prospective study. J Gastroenterol 2004;39:1158-1164
6. Ljung T, Thomsen OO, Vatn M, Karlen P, Karlsen LN, Tysk C, Nilsson SU, Kilander A, Gillberg R, Grip O, Lindgren S, Befrits R, Lofberg R: Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: The first 100 patients treated in Scandinavia. Scand J Gastroenterol 2007;42:221-227
7. Sakuraba A, Motoya S, Watanabe K, Nishishita M, Kanke K, Matsui T, Suzuki Y, Oshima T, Kunisaki R, Matsumoto T, Hanai H, Fukunaga K, Yoshimura N, Chiba T, Funakoshi S, Aoyama N, Andoh A, Nakase H, Mizuta Y, Suzuki R, Akamatsu T, Iizuka M, Ashida T, Hibi T: An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol 2009;104:2990-2995
8. Sands BE, Sandborn WJ, Feagan B, Lofberg R, Hibi T, Wang T, Gustofson LM, Wong CJ, Vandervoort MK, Hanauer S: A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Gastroenterology 2008;135:400-409
9. Ozeki K, Tanida S, Mizushima T, Mizoshita T, Tsukamoto H, Hirata Y, Murakami K, Shimura T, Kataoka H, Kamiya T, Joh T: Combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn's disease patient with the loss of response to scheduled adalimumab maintenance therapy: A case report. Intern Med 2012;51:595-599
10. Daperno M, D'Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, Sostegni R, Rocca R, Pera A, Gevers A, Mary JY, Colombel JF, Rutgeerts P: Development and validation of a new, simplified endoscopic activity score for Crohn's disease: The SES-CD. Gastrointest Endosc 2004;60:505-512
11. Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Colombel JF, Panaccione R, D'Haens G, Li J, Rosenfeld MR, Kent JD, Pollack PF: Adalimumab induction therapy for Crohn disease previously treated with infliximab: A randomized trial. Ann Intern Med 2007;146:829-838
12. Kashiwagi N, Hirata I, Kasukawa R: A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher 1998;2:134-141
13. Saniabadi AR, Hanai H, Takeuchi K, Umemura K, Nakashima M, Adachi T, Shima C, Bjarnason I, Lofberg R: Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 2003;7:48-59
14. Gonzalez Carro P, Perez Roldan F, Roncero Garcia Escribano O, Lafuente R, Legaz Huidobro ML, Amigo Echenagusia A: Case report: Combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease. J Clin Apher 2006;21:249-251
15. Allez M, Lemann M, Bonnet J, Cattan P, Jian R, Modigliani R: Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy. Am J Gastroenterol 2002;97: 947-953.